Sartorius Stedim Biotech and Siemens agreed a long-term cooperation

| By | Pharmaceutical Equipment, Technological Equipment
0
73

The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation.

This agreement provides that Sartorius Stedim Biotech will preferably use Siemens automation technologies, which will include industrial PCs, the S7-1500 software controller, the TIA Portal and the SCADA system Simatic WinCC, among others. These hardware and software components will be employed in many products and solutions that SSB offers its customers for the development and manufacture of biopharmaceuticals, such as vaccines and monoclonal antibodies.

Sartorius Stedim Biotech has already been using established Siemens automation solutions for process control in its large-scale bioreactor and filtration systems for quite some time. To standardize its own product portfolio even further, SSB has decided to introduce a new, configurable automation system for its range of systems. Under the agreement recently concluded, cooperation between the two companies will therefore be extended to further Sartorius Stedim Biotech products. These will be successively equipped with Siemens automated solutions in the coming months and can thus be integrated into process control systems such as Simatic PCS 7 and Simatic Batch. Essentially, such SSB products are single-use bioreactors of the BIOSTAT STR series, various filtration systems and the FlexAct system. The latter is a flexible module that is used to control many different process steps within biopharmaceutical production.

Siemens AG (Berlin and Munich, Germany) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years.

Sartorius Stedim Biotech is a leading international supplier of products and services to the biopharmaceutical industry. Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech, has manufacturing and R&D sites in Europe, North America and Asia.

SOURCE: siemens
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.